('and', 39)('of', 23)('the', 18)('*', 13)('in', 12)('to', 11)('for', 10)('-', 9)('a', 8)('is', 7)(')', 7)('MD', 6)('Bethesda', 6)('NCI', 6)('Research', 6)('support', 6)('as', 6)('at', 6)('data', 5)('development', 5)('The', 5)('Leidos', 5)('analysis', 5)('activities', 4)('Bioinformatics', 4)('III', 4)('Biomedical', 4)('National', 4)('Inc.', 4)('Cancer', 4)('Analyst', 4)('with', 4)('an', 4)('experience', 3)('bioinformatics', 3)('biomedical', 3)('responsible', 3)('cancer', 3)('Center', 3)('will', 3)('Institute', 3)('or', 3)('be', 3)('QUALIFICATIONS', 2)('research', 2)('degree', 2)('from', 2)('FFRDC', 2)('following', 2)('Corporation', 2)('Familiarity', 2)('1', 2)('effective', 2)('operations', 2)('interpretation', 2)('years', 2)('workflows', 2)('related', 2)('programming', 2)('proteomics', 2)('approximately', 2)('least', 2)('2', 2)('Rockville', 2)('632677', 2)('Frederick', 2)('(NCI)', 2)('R', 2)('high-throughput', 2)('(', 2)('NIH', 2)('FNLCR', 2)('developing', 2)('technology', 2)('microarray', 2)('PAREXEL', 2)('programs', 2)('well', 2)('4', 2)('sequencing', 2)('like', 2)('International', 2)('provides', 2)('scientific', 2)('by', 2)('on', 2)('Knowledge', 2)('clinical', 2)('(NCI).', 2)('5', 2)('DESCRIPTION', 2)('breadth', 1)('results', 1)('four', 1)('facilities', 1)('manages', 1)('follow', 1)('environment', 1)('under', 1)('insights', 1)('team', 1)('biological', 1)('cBioPortal', 1)('concise', 1)('M.', 1)('design', 1)('PREFERRED', 1)('Collins', 1)('campuses', 1)('COMPANY', 1)('investigator-initiated', 1)('current', 1)('designing', 1)('new', 1)('public', 1)('(FFRDC)', 1)('understanding', 1)('focused', 1)('groups', 1)('others', 1)('languages:', 1)('(LBRI)', 1)('900', 1)('employees', 1)('TCGA', 1)('products', 1)('Technology', 1)('Samtools', 1)('tools', 1)('genomics', 1)('FireHose', 1)('working', 1)('BWA', 1)('visit', 1)('two', 1)('more', 1)('must', 1)('this', 1)('work', 1)('Inc', 1)('dedicated', 1)('high', 1)('effectively', 1)('minimum', 1)('information', 1)('located', 1)('biopharmaceutical', 1)('animal', 1)('A', 1)('Foreign', 1)('documentation', 1)('Deep', 1)('hypotheses', 1)('Python', 1)('maintain', 1)('progressively', 1)('preventive', 1)('webpage', 1)('experiments', 1)('including', 1)('statistical', 1)('Equivalency', 1)('its', 1)('Higher', 1)('accredited', 1)('JOB', 1)('degrees', 1)('main', 1)('designs', 1)('emailed', 1)('Solid', 1)('owned', 1)('data-processing:', 1)('not', 1)('university', 1)('proteins', 1)('NIAID.', 1)('(ABCC)', 1)('applied', 1)('Council', 1)('|', 1)('investigators', 1)('STAR', 1)('Accreditation', 1)('Perl', 1)('NGS', 1)('our', 1)('research.', 1)('Practice', 1)('wholly', 1)('safety', 1)('GATK', 1)('receiving', 1)('AIDS.', 1)('high-performance', 1)('This', 1)('diagnostic', 1)('imaging', 1)('generate', 1)('training', 1)('450', 1)('CWPS', 1)('(CHEA)', 1)('Program', 1)('AIDS', 1)('management', 1)('Data', 1)('mining', 1)('DESeq', 1)('C/C++', 1)('part', 1)('to:', 1)('Consulting', 1)('database', 1)('next-generation', 1)('providing', 1)('Information', 1)('spectrum', 1)('It', 1)('manner', 1)('BASIC', 1)('Administrative', 1)('Development', 1)('Diseases', 1)('sciences', 1)('data:', 1)('Novoalign', 1)('collaboration', 1)('state-of-the-art', 1)('sponsored', 1)('scripts', 1)('(CCR)', 1)('clear', 1)('Majority', 1)('S/he', 1)("Bachelor's", 1)('R&amp', 1)('only', 1)('Federally', 1)('Services', 1)('familiar', 1)('scientists', 1)('Funded', 1)('Cape', 1)('resource', 1)('Facilities', 1)('analytical', 1)('through', 1)('Education', 1)('For', 1)('national', 1)('Fox', 1)('operates', 1)('college', 1)('deploying', 1)('Good', 1)('Ability', 1)('please', 1)('Annotator', 1)('3', 1)('conditions', 1)('Advanced', 1)('discovery', 1)('available', 1)('jobs', 1)('U.S.', 1)('analyses.', 1)('packages', 1)('$', 1)('throughput', 1)('annual', 1)('according', 1)('drug', 1)('Strategic', 1)('Through', 1)('Laboratory', 1)('ChIPSeq', 1)('Bethesda.', 1)('experimental', 1)('among', 1)('relevant', 1)('ABCC', 1)('spans', 1)('three', 1)('MATLAB', 1)('expected', 1)('life', 1)('understand', 1)('sound', 1)('novel', 1)('publicly', 1)('these', 1)('budget', 1)('evaluated', 1)('Expertise', 1)('Limma', 1)('cluster', 1)('EdgeR', 1)('You', 1)('member', 1)('complex', 1)('Metagenomics', 1)('consultation', 1)('status', 1)('{emailaddress}', 1)('cleaning', 1)('robust', 1)('normalization', 1)('spent', 1)('procurement', 1)('practices', 1)('coordinate', 1)('position', 1)("FNLCR's", 1)('visualization', 1)('processes.', 1)('LBRI', 1)('has', 1)('D', 1)('five', 1)('background', 1)('using', 1)('nanotechnology', 1)('unique', 1)('advanced', 1)('RNASeq', 1)('NCBI', 1)('Computing', 1)('audience', 1)('hypothesis-driven', 1)('therapeutic', 1)('Java', 1)('Broad', 1)('platforms', 1)('accelerate', 1)('provided', 1)('genetics', 1)('metabolomics', 1)('Description:', 1)('(FNLCR).', 1)('INFORMATION', 1)('biology', 1)('business', 1)('ExomeSeq', 1)('processing', 1)('Infectious', 1)('InCadence', 1)('Ensembl', 1)('manufacturing', 1)('about', 1)('staff.', 1)('science/bioinformatics/math/physics/computer', 1)('Solutions', 1)('efforts', 1)('(NIAID)-sponsored', 1)('into', 1)('PROGRAM', 1)('lieu', 1)('financial', 1)('statistics', 1)('custom', 1)('start', 1)('analyze', 1)('Science', 1)('databases:', 1)('Experience', 1)('delivery', 1)('subsidiary', 1)('operating', 1)('DHS-Seq', 1)('Gaithersburg', 1)('computing', 1)('www.leidosbiomed.com.', 1)('laboratory', 1)('SnpEff', 1)('campus', 1)('technologies.', 1)('trials', 1)('Proficiency', 1)('field', 1)('areas:', 1)('other', 1)('Manufacturing', 1)('collaborative', 1)('generated', 1)('Qualifications:', 1)('Allergy', 1)('presenting', 1)('time', 1)('Jobs.com', 1)    632677 - Bioinformatics Analyst III (NCI) - Leidos | Jobs.com
        Description:
        COMPANY INFORMATION
        Leidos Biomedical Research, Inc. (LBRI), a wholly owned subsidiary of Leidos, operates the Frederick National Laboratory for Cancer Research (FNLCR). FNLCR is a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI). It is the only FFRDC dedicated to biomedical research. Through its status as an FFRDC, FNLCR provides NCI and others with a unique national resource to accelerate the development and delivery of effective preventive, diagnostic, and therapeutic products for cancer and AIDS.
        The breadth of FNLCR's activities spans the research and development spectrum, including investigator-initiated, hypothesis-driven research into cancer and AIDS; advanced technology programs focused on genetics and genomics, proteins and proteomics, imaging, nanotechnology, bioinformatics, and laboratory animal sciences; clinical operations in support of NCI and National Institute of Allergy and Infectious Diseases (NIAID)-sponsored clinical trials, as well as NCI drug discovery and development efforts; and management and operations of biopharmaceutical development and manufacturing programs under current Good Manufacturing Practice conditions for NCI and NIAID. Administrative, procurement, financial, safety, and facilities support is provided to these R&amp;D activities through state-of-the-art business processes. LBRI has approximately 1,900 employees and manages an annual operating budget of approximately $450M.
        For more information about Leidos Biomedical Research Inc., please visit our webpage at www.leidosbiomed.com.
        PROGRAM DESCRIPTION
        The Advanced Biomedical Computing Center (ABCC) is a part of the Data Science and Information Technology Program at Leidos Biomedical Research, Inc. The ABCC provides technology development, scientific consultation, collaboration and training, and high-performance computing support to the NCI and NIH scientists and staff.
        JOB DESCRIPTION
        The Bioinformatics Analyst III is responsible for providing collaborative bioinformatics support to the investigators at the National Cancer Institute (NCI). S/he is responsible for 1) the analysis and interpretation of high-throughput biomedical data generated by microarray, next-generation sequencing, proteomics and metabolomics platforms, 2) designing, developing and deploying robust workflows, as well as custom scripts, to support the analysis of high-throughput data, 3) mining publicly available biological data to generate novel hypotheses or insights, 4) presenting analysis results, in a clear and concise manner, to an audience not familiar with bioinformatics, and 5) developing analytical workflows for new sequencing technologies.
        The Bioinformatics Analyst III is expected to work effectively as a member of a team; coordinate activities among other groups located at the Bethesda, Frederick, Rockville and Gaithersburg NCI campuses; follow sound scientific practices and maintain effective documentation of activities and analyses.
        Majority of time will be spent on the main NIH campus in Bethesda. This position will be in support of the Center for Cancer Research (CCR)
        Qualifications:
        BASIC QUALIFICATIONS
        * Bachelor's degree in life science/bioinformatics/math/physics/computer related field from an accredited college or university according to the Council for Higher Education Accreditation (CHEA) or four (4) years related experience in lieu of degree
        * Foreign degrees must be evaluated for U.S. Equivalency
        * A minimum of five (5) years of progressively responsible relevant experience
        * Deep understanding of and experience in processing high throughput biomedical data: data cleaning, normalization, analysis, interpretation and visualization
        * Ability to understand and analyze data from complex experimental designs
        * Solid background in the applied statistics and design of experiments
        * Proficiency in at least two of the following programming languages: Perl, Python, R, Java and C/C++
        * Experience in at least three of the following areas: Metagenomics, ChIPSeq, RNASeq, ExomeSeq, DHS-Seq, microarray analysis
        * Expertise in using tools for NGS data-processing: Novoalign, STAR, BWA, GATK, Samtools, Annotator, SnpEff, Limma, EdgeR, DESeq2
        * Familiarity with public databases: NCBI, Ensembl, TCGA, cBioPortal, Broad FireHose
        * Familiarity with statistical packages like R and MATLAB
        * Knowledge of cancer biology
        * Knowledge of database programming and working in a cluster environment
        PREFERRED QUALIFICATIONS
             Cape Fox Facilities Services, Bethesda - MD
             InCadence Strategic Solutions, Bethesda - MD
             PAREXEL International Corporation, Bethesda - MD
             PAREXEL International Corporation, Bethesda - MD
             Collins Consulting, Inc., Bethesda - MD
             CWPS Inc, Rockville - MD
          632677 - Bioinformatics Analyst III (NCI)
        You will start receiving jobs like this emailed to: {emailaddress}